Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold Ganser

Showing results (1-10 of 490) with videos related to

Pageof 49
Sort By:
Haematologica|January 9, 2025
We still need to hit hard in acute myeloid leukemia, but only in the right patientsArnold Ganser
Seminars in Hematology|July 17, 2007
Hematopoietic growth factors--present status and future developmentArnold Ganser
Haematologica|October 14, 2021
Is allogeneic transplantation the preferred therapy for older patients with acute myeloid leukemia?Arnold Ganser
British Journal of Haematology|September 12, 2025
The British Journal of Haematology celebrates its 70th birthday. Part one: Malignant haematology 2018-2024Arnold Ganser
Blood|May 20, 2021
What can Heraclitus tell us about AML?Arnold Ganser
Haematologica|March 8, 2005
Long-term bone marrow culture data is the most powerful predictor for peripheral blood progenitor cell mobilization in healthy donorsArnold Ganser
Blood|January 19, 2023
Role of allotransplantation in older patients with AMLArnold Ganser
Frontiers of Medicine in China|December 3, 2010
Molecular pathogenesis of acute myeloid leukemia: a diverse disease with new perspectivesFelicitas Thol, Arnold Ganser
Current Pharmaceutical Design|May 11, 2012
Immunosuppressive therapy for myelodysplastic syndromesChristiane Dobbelstein, Arnold Ganser
Annals of Hematology|July 28, 2005
Colony-stimulating factors in the management of neutropenia and its complicationsMichael Heuser, Arnold Ganser
Pageof 49

Showing results (1-10 of 490) with videos related to

Sort By:
Pageof 49
Haematologica|January 9, 2025
We still need to hit hard in acute myeloid leukemia, but only in the right patientsArnold Ganser
Seminars in Hematology|July 17, 2007
Hematopoietic growth factors--present status and future developmentArnold Ganser
Haematologica|October 14, 2021
Is allogeneic transplantation the preferred therapy for older patients with acute myeloid leukemia?Arnold Ganser
British Journal of Haematology|September 12, 2025
The British Journal of Haematology celebrates its 70th birthday. Part one: Malignant haematology 2018-2024Arnold Ganser
Blood|May 20, 2021
What can Heraclitus tell us about AML?Arnold Ganser
Haematologica|March 8, 2005
Long-term bone marrow culture data is the most powerful predictor for peripheral blood progenitor cell mobilization in healthy donorsArnold Ganser
Blood|January 19, 2023
Role of allotransplantation in older patients with AMLArnold Ganser
Frontiers of Medicine in China|December 3, 2010
Molecular pathogenesis of acute myeloid leukemia: a diverse disease with new perspectivesFelicitas Thol, Arnold Ganser
Current Pharmaceutical Design|May 11, 2012
Immunosuppressive therapy for myelodysplastic syndromesChristiane Dobbelstein, Arnold Ganser
Annals of Hematology|July 28, 2005
Colony-stimulating factors in the management of neutropenia and its complicationsMichael Heuser, Arnold Ganser
Pageof 49